ENVB

$1.50+3.45%visit website

Enveric Biosciences, Inc.

Market Cap

$7M

Live price × SEC shares (Aug 12, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

1.20

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

0.8

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	402	372	346	1,355	2,476
Total operating expenses				3,027
Operating income	(1,874)	(2,194)	(1,633)	(3,027)	(8,728)
Pretax income	(1,874)	(2,194)	(1,633)	(3,028)	(8,729)
Net income	(1,874)	(2,194)	(1,633)	(3,028)	(8,729)
EPS (basic) ($)	(10.81)		(1.08)	(0.76)	—
EPS (diluted) ($)	(10.81)		(1.08)	(0.76)	—
Weighted avg. shares (basic)	313		1,510	3,987
Weighted avg. shares (diluted)	313		1,510	3,987

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

15 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 14, 2026 accepted 4:15 PM ET	2.02Earnings release	Document SEC ↗
Jun 9, 2026 accepted 5:16 PM ET	8.01Other events	Document SEC ↗
Jun 9, 2026 accepted 5:53 PM ET	7.01Reg FD disclosure	Document SEC ↗
May 29, 2026 accepted 4:13 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
May 15, 2026 accepted 8:00 AM ET	2.02Earnings release	Document SEC ↗
Apr 30, 2026 accepted 4:02 PM ET	8.01Other events	Document SEC ↗
Apr 20, 2026 accepted 6:15 PM ET	1.01Material agreement3.02Unregistered equity sale8.01Other events	Document SEC ↗
Mar 27, 2026 accepted 5:25 PM ET	2.02Earnings release	Document SEC ↗
Feb 6, 2026 accepted 4:45 PM ET	8.01Other events	Document SEC ↗
Jan 28, 2026 accepted 5:00 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗